Bladder cancer
Conditions
Interventions
Sponsors
Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine
Eligibility
Sex/Gender
Male
Age
25 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1. In line with transurethral resection of bladder tumor (TURPBT), and pathological diagnosis of malignant tumors; 2. The Karnofsky Performance Status (KPS) score >60 points, and the expected survival period >1 year; 3. Aged 25 to 80 years; 4. Those who have voluntarily signed an informed consent form.
Exclusion criteria
Exclusion criteria: 1. Allergic constitution and those who are allergic to experimental drugs; 2. Patients with renal cancer, bladder tuberculosis, and urinary calculi; 3. Combined with other malignant tumor patients; 4. Patients with blood system diseases, coagulopathy and autoimmune diseases; 5. Combined with severe cardiovascular disease, cerebrovascular disease, hematopoietic system disease, neuropathic patients; 6. Participated in other clinical researchers 3 months before the trial; 7. Non-resection of bladder tumors.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Tumor patient Karnofsky Performance Status; | — |
Secondary
| Measure | Time frame |
|---|---|
| Bladder cancer syndrome score; | — |
Countries
China
Contacts
Public ContactYaosheng Zhang
Department of Urology, Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine
Outcome results
None listed